Martha Stanko

NPI: 1427542877
Total Payments
$18.69
2021 Payments
$18.69
Companies
1
Transactions
2
Medicare Patients
969
Medicare Billing
$75,523

Payment Breakdown by Category

Food & Beverage$18.69 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $18.69 2 100.0%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $18.69 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2021 $18.69 2 Genentech USA, Inc. ($18.69)

All Payment Transactions

2 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
01/29/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $11.75 General
Category: Virology & Specialty Care
01/22/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $6.94 General
Category: Virology & Specialty Care

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 270 293 $35,749 $16,613
2022 5 161 175 $24,191 $13,760
2021 5 164 174 $23,828 $14,388
2020 7 374 390 $51,780 $30,763
Total Patients
969
Total Services
1,032
Medicare Billing
$75,523
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 53 57 $9,390 $5,209 55.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 71 72 $10,425 $4,316 41.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 22 22 $4,422 $2,288 51.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 28 28 $4,060 $2,173 53.5%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 48 52 $5,200 $1,800 34.6%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 13 26 $1,326 $421.72 31.8%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2023 22 22 $660.00 $356.40 54.0%
81002 Urinalysis, manual test Office 2023 13 14 $266.00 $47.74 17.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 50 61 $8,845 $4,742 53.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 28 30 $4,350 $3,264 75.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 33 33 $4,785 $2,761 57.7%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 39 40 $4,000 $1,672 41.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 11 11 $2,211 $1,321 59.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 60 66 $9,190 $5,019 54.6%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 41 41 $5,900 $3,965 67.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 13 13 $2,613 $1,888 72.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 17 18 $2,525 $1,887 74.7%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 33 36 $3,600 $1,628 45.2%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 188 188 $29,381 $18,419 62.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 98 113 $15,688 $9,410 60.0%
99202 New patient office or other outpatient visit, typically 20 minutes Office 2020 27 27 $3,364 $1,980 58.8%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 15 16 $1,552 $707.52 45.6%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 13 13 $1,110 $158.52 14.3%
36415 Insertion of needle into vein for collection of blood sample Office 2020 19 19 $391.00 $56.94 14.6%
81003 Automated urinalysis test Office 2020 14 14 $294.00 $31.25 10.6%

About Martha Stanko

Martha Stanko is a Physician Assistant healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2018. The National Provider Identifier (NPI) number assigned to this provider is 1427542877.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Martha Stanko has received a total of $18.69 in payments from pharmaceutical and medical device companies, with $18.69 received in 2021. These payments were reported across 2 transactions from 1 company. The most common payment nature is "Food and Beverage" ($18.69).

As a Medicare-enrolled provider, Stanko has provided services to 969 Medicare beneficiaries, totaling 1,032 services with total Medicare billing of $75,523. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Morris Plains, NJ
  • Active Since 06/19/2018
  • Last Updated 06/19/2018
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1427542877

Products in Payments

  • Xofluza (Drug) $18.69

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Morris Plains